Harvard Bioscience Inc
NASDAQ:HBIO
Wall Street
Price Targets
HBIO Price Targets Summary
Harvard Bioscience Inc
According to Wall Street analysts, the average 1-year price target for
HBIO
is 7.06 USD
with a low forecast of 6.82 USD and a high forecast of 7.35 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HBIO's stock price target?
Price Target
7.06
USD
According to Wall Street analysts, the average 1-year price target for
HBIO
is 7.06 USD
with a low forecast of 6.82 USD and a high forecast of 7.35 USD.
What is Harvard Bioscience Inc's Revenue forecast?
Projected CAGR
8%
For the last 8 years the
compound annual growth rate for
Harvard Bioscience Inc's revenue is
0%.
The projected
CAGR
for the next 3 years is
8%.
What is Harvard Bioscience Inc's Operating Income forecast?
Projected CAGR
73%
The
compound annual growth rate
of Harvard Bioscience Inc's operating income for the next 3 years is
73%.
You don't have any saved screeners yet
